tiprankstipranks
Trending News
More News >
XBiotech (XBIT)
NASDAQ:XBIT
US Market

XBiotech (XBIT) Financial Statements

Compare
340 Followers

XBiotech Financial Overview

XBiotech's market cap is currently $72.87M. The company's EPS TTM is $-1.264; its P/E ratio is -0.68; XBiotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 4.01M$ 18.39M
Gross Profit$ -1.69M$ 0.00$ 0.00$ 3.36M$ 12.57M
Operating Income$ -55.69M$ -42.47M$ -37.51M$ -34.49M$ -25.08M
EBITDA$ -54.00M$ -36.01M$ -22.57M$ -31.88M$ -22.43M
Net Income$ -45.54M$ -38.53M$ -24.56M$ -32.90M$ -17.41M
Balance Sheet
Cash & Short-Term Investments$ 125.55M$ 172.68M$ 200.02M$ 217.48M$ 236.98M
Total Assets$ 150.08M$ 199.09M$ 226.62M$ 246.10M$ 275.18M
Total Debt$ 0.00$ 10.25M$ 0.00$ 0.00$ 0.00
Net Debt$ -125.55M$ -162.43M$ -200.02M$ -157.31M$ -236.98M
Total Liabilities$ 9.73M$ 16.82M$ 7.77M$ 5.70M$ 5.79M
Stockholders' Equity$ 140.35M$ 182.27M$ 218.85M$ 240.40M$ 269.38M
Cash Flow
Free Cash Flow$ -40.21M$ -32.27M$ -19.09M$ -15.41M$ 65.92M
Operating Cash Flow$ -39.92M$ -30.96M$ -18.73M$ -14.82M$ 69.44M
Investing Cash Flow$ -289.00K$ -1.30M$ 61.50M$ -63.89M$ -3.52M
Financing Cash Flow$ -10.25M$ 10.45M$ -9.00K$ 0.00$ -67.01M
Currency in USD

XBiotech Earnings and Revenue History

XBiotech Debt to Assets

XBiotech Cash Flow

XBiotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.